Publications

Found 1 results
Filters: Author is M.-Y. Sun  [Clear All Filters]
2012
M. - Y. Sun, Yang, X. - X., Xu, W. - W., Yao, G. - Y., Pan, H. - Z., and Li, M., Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China, vol. 11, pp. 4330-4341, 2012.
Bestor TH (2000). The DNA methyltransferases of mammals. Hum. Mol. Genet. 9: 2395-2402. http://dx.doi.org/10.1093/hmg/9.16.2395 PMid:11005794   Brenner C, Deplus R, Didelot C, Loriot A, et al. (2005). Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24: 336-346. http://dx.doi.org/10.1038/sj.emboj.7600509 PMid:15616584 PMCid:545804   Cai FF, Kohler C, Zhang B, Wang MH, et al. (2011). Epigenetic therapy for breast cancer. Int. J. Mol. Sci. 12: 4465-4487. http://dx.doi.org/10.3390/ijms12074465 PMid:21845090 PMCid:3155363   Cebrian A, Pharoah PD, Ahmed S, Ropero S, et al. (2006). Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 27: 1661-1669. http://dx.doi.org/10.1093/carcin/bgi375 PMid:16501248   Deplus R, Brenner C, Burgers WA, Putmans P, et al. (2002). Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res. 30: 3831-3838. http://dx.doi.org/10.1093/nar/gkf509 PMid:12202768 PMCid:137431   Easwaran HP, Schermelleh L, Leonhardt H and Cardoso MC (2004). Replication-independent chromatin loading of Dnmt1 during G2 and M phases. EMBO Rep. 5: 1181-1186. http://dx.doi.org/10.1038/sj.embor.7400295 PMid:15550930 PMCid:1299190   Egger G, Liang G, Aparicio A and Jones PA (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463. http://dx.doi.org/10.1038/nature02625 PMid:15164071   Ehrlich M (2002). DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413. http://dx.doi.org/10.1038/sj.onc.1205651 PMid:12154403   Esteller M, Silva JM, Dominguez G, Bonilla F, et al. (2000). Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92: 564-569. http://dx.doi.org/10.1093/jnci/92.7.564 PMid:10749912   Fan H, Liu D, Qiu X, Qiao F, et al. (2010). A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma. BMC Med. 8: 12. http://dx.doi.org/10.1186/1741-7015-8-12 PMid:20128888 PMCid:2829483   Franke A, McGovern DP, Barrett JC, Wang K, et al. (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42: 1118-1125. http://dx.doi.org/10.1038/ng.717 PMid:21102463 PMCid:3299551   Fuks F, Burgers WA, Godin N, Kasai M, et al. (2001). Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20: 2536-2544. http://dx.doi.org/10.1093/emboj/20.10.2536 PMid:11350943 PMCid:125250   Goll MG, Kirpekar F, Maggert KA, Yoder JA, et al. (2006). Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 311: 395-398. http://dx.doi.org/10.1126/science.1120976 PMid:16424344   Gudbjartsson DF, Walters GB, Thorleifsson G, Stefansson H, et al. (2008). Many sequence variants affecting diversity of adult human height. Nat. Genet. 40: 609-615. http://dx.doi.org/10.1038/ng.122 PMid:18391951   Haggarty P, Hoad G, Harris SE, Starr JM, et al. (2010). Human intelligence and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking. PLoS One 5: e11329. http://dx.doi.org/10.1371/journal.pone.0011329 PMid:20593030 PMCid:2892514   Herman JG and Baylin SB (2003). Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349: 2042-2054. http://dx.doi.org/10.1056/NEJMra023075 PMid:14627790   Hu J, Fan H, Liu D, Zhang S, et al. (2010). DNMT3B promoter polymorphism and risk of gastric cancer. Dig. Dis. Sci. 55: 1011-1016. http://dx.doi.org/10.1007/s10620-009-0831-3 PMid:19517237   Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90. http://dx.doi.org/10.3322/caac.20107 PMid:21296855   Jones PA and Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428. PMid:12042769   Kanai Y, Ushijima S, Nakanishi Y, Sakamoto M, et al. (2003). Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett. 192: 75-82. http://dx.doi.org/10.1016/S0304-3835(02)00689-4   Kang ES, Park CW and Chung JH (2001). Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. Biochem. Biophys. Res. Commun. 289: 862-868. http://dx.doi.org/10.1006/bbrc.2001.6057 PMid:11735126   Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, et al. (2008). Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res. 68: 2498-2506. http://dx.doi.org/10.1158/0008-5472.CAN-07-5165 PMid:18381459 PMCid:2786310   Kim GD, Ni J, Kelesoglu N, Roberts RJ, et al. (2002). Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21: 4183-4195. http://dx.doi.org/10.1093/emboj/cdf401 PMid:12145218 PMCid:126147   Lee SJ, Jeon HS, Jang JS, Park SH, et al. (2005). DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26: 403-409. http://dx.doi.org/10.1093/carcin/bgh307 PMid:15528220   Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, et al. (2003). Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13: 1192-1200. http://dx.doi.org/10.1016/S0960-9822(03)00432-9